ArticlePakistan journal of medical sciences2026
Correlation of serum CTRP9 and CTRP15 levels with HOMA-IR and HOMA-B in metabolic syndrome patients with and without coronary artery disease.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate and compare the serum levels of CTRP9, CTRP15, HOMA-IR, and HOMA-B in metabolic syndrome patients, with and without coexisting coronary artery disease. Methodology: This was a cross-sectional comparative study involving two groups, each with 40 patients. Group-A comprised metabolic syndrome patients with coronary artery disease, whereas Group-B included metabolic syndrome patients without coronary artery disease. The study was carried out from September 20 Results: The systolic (p=0.012) as well as diastolic (p=0.001) blood pressure and serum low-density lipoprotein cholesterol (p=0.032) was significantly higher in the Group-A when compared with the Group-B. Serum high-density lipoprotein was significantly lower (p = 0.031) in Group-A compared to Group-B. Significantly elevated levels of HOMA-IR (p=0.001), and CTRP15 (p=0.001) were present in Group-A as compared to the Group-B. A statistically significant negative correlation was observed between HOMA-B and CTRP15 serum levels (rho=-0.356, p=0.024) in Group-A. Conclusion: In this study, decreased insulin secretion was found to correlate with increased CTRP15 levels in patients with metabolic syndrome and coronary artery disease. This finding suggests the potential role of CTRP15 in the pathophysiology of beta cell dysfunction possibly reflecting either a state of CTRP15 resistance or a compensatory response to impaired insulin secretion.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.